Suchergebnisse - "Sive, Jonathan"

PubPharm (56)

21

Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders : influence of host and disease factors

enthalten in: British journal of haematology | 2022

von Chan, W. | Howells, L. | Wilson, W. | +19

22

Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV‐19 COVID‐19 vaccine after first and second doses in patients with plasma cell disorders : influence of host and disease factors

enthalten in: British Journal of Haematology | 2022

von Chan, W. | Howells, L. | Wilson, W. | +19

23

Rasch‐built overall disability scale for POEMS syndrome ( POEMS‐RODS)

enthalten in: Journal of the Peripheral Nervous System | 2022

von Keh, R. | Lilleker, J. | Lavin, T. | +5

24

Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients

enthalten in: Leukemia & lymphoma | 2021

von Camilleri, M. | McGrath, T. | Wilson, W. | +9

25

Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients : single-center UK experience

enthalten in: Leukemia & lymphoma | 2021

von Richards, H. | Chavda, S. | Wilson, W. | +12

26

Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy

enthalten in: British journal of haematology | 2021

von Chan, W. | Sanchez, E. | Chavda, S. | +14

27

Ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma : impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set

enthalten in: Leukemia & lymphoma | 2021

von Ziff, M. | Lawson, G. | De-Silva, D. | +10

28

Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study

enthalten in: British journal of haematology | 2021

von Camilleri, M. | Cuadrado, M. | Phillips, E. | +21

29

Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high-risk myeloma patients - a single centre experience

enthalten in: British journal of haematology | 2021

von Jurgensen-Rauch, A. | Gibbs, S. | Farrell, M. | +9

30

Guidelines on the diagnosis, investigation and initial treatment of myeloma : a British Society for Haematology/UK Myeloma Forum Guideline

enthalten in: British journal of haematology | 2021

von Sive, J. | Cuthill, K. | Hunter, H. | +4

CommentIn: Br J Haematol. 2021 Apr;193(2):213-215. - PMID 33748954